Cassava Sciences Inc logo

SAVA

Cassava Sciences Inc

$24.12

Earnings Summary

Revenue
$0Mn
Net Profits
$-20.26Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Cassava Sciences Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2022. On a quarterly growth basis, Cassava Sciences Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Cassava Sciences Inc’s net profit fell -111.85% since last year same period to $-20.26Mn in the Q3 2022. On a quarterly growth basis, Cassava Sciences Inc has generated -4.81% fall in its net profits since last 3-months.

Net Profit Margins:

Cassava Sciences Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2022. On a quarterly growth basis, Cassava Sciences Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Cassava Sciences Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.54
EPS Estimate Current Year
-0.54

Highlights

EPS Estimate Current Quarter:

Cassava Sciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.54 - a -12.5% fall from last quarter’s estimates.

EPS Estimate Current Year:

Cassava Sciences Inc’s earning per share (EPS) estimates for the current year stand at -0.54.

Key Ratios

Key ratios of the Cassava Sciences Inc post its Q4 2022 earnings

Return on Assets (ROA)
-0.2
Return on Equity (ROE)
-0.32

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Cassava Sciences Inc’s return on assets (ROA) stands at -0.2.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Cassava Sciences Inc’s return on equity (ROE) stands at -0.32.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2016-07-19
-0.98
-0.49
50%
2016-10-26
-0.63
-0.56
11.11%
2016-05-05
-0.7
-0.91
-30%
2017-03-07
-0.56
-0.42
25%

Company Information

Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer's disease.

Organisation
Cassava Sciences Inc
Headquarters
7801 North Capital of Texas Highway, Austin, TX, United States, 78731
Employees
26
Industry
Pharmaceuticals: Other
CEO
Remi Barbier